April 21 (Reuters) - Indian healthcare services provider
Narayana Hrudayalaya Ltd NARY.NS said it would buy NewRise
Healthcare Private Ltd from Panacea Biotec Ltd PNCA.NS for an
enterprise value of 1.80 billion rupees ($27.87 million).
The acquisition will help expand its footprint in Gurugram
in northern India, Narayana Hrudayalaya said on Friday. http://bit.ly/2oayd4R
NewRise Healthcare, the 230-bed multi-speciality hospital,
is in final stages of completion, and is likely to be
commissioned in the next nine months, Bengaluru-based Narayana
Hrudayalaya added.
On a separate note, Panacea Biotec said its associate
company PanEra Biotec Private Ltd would sell all of its
preference shares in NewRise Healthcare to Narayana Hrudayalaya.
Shares of New Delhi-based Panacea Biotec jumped as much as
9.8 percent, to their highest since March 2, while Narayana
Hrudayalaya's stocks were little changed.
($1 = 64.5850 Indian rupees)
(Reporting by Tanvi Mehta in Bengaluru; Editing by Sherry
Jacob-Phillips)
((tanvi.mehta@thomsonreuters.com; +91 80 67494756 ; Reuters
Messaging: tanvi.mehta.thomsonreuters.com@reuters.net))
Keywords: NEWRISEHEALTHCARE M&A/NARAYANA